- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Human Genome Sciences Inc
Add to PortfolioHGSI:US
13.6100 USD 0.0100 0.07%As of 20:10:00 ET on 05/25/2012.
Snapshot for Human Genome Sciences Inc (HGSI)
| Open: | 13.4500 | Day's Range: | 13.4500 - 13.7700 | Volume: | 2,868,244 | Bid: | 13.6100 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 13.6200 | 52wk Range: | 6.5100 - 27.4600 | 1-Yr Rtn: | -49.50% | Ask: | 13.6200 |
Key Statistics for HGSI
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E (12/2012) | - |
| Earnings Per Share (USD) (ttm) | -1.7500 |
| Est. EPS (USD) (12/2012) | -1.3710 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 2,709.36 |
| Shares Outstanding (M) | 199.07 |
| Enterprise Value (M USD) (ttm) | 2,811.67 |
| Enterprise Value/EBITDA (ttm) | - |
| Price/Book (mrq) | 7.1929 |
| Price/Sale (ttm) | 17.6809 |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | 07/20/2012 |
More HGSI Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for HGSI
- Operating
- Investing
- Financing (M/USD)
Company Profile & Key Executives for HGSI
Human Genome Sciences, Inc. researches and develops proprietary pharmaceutical and diagnostic products. The Company's products predict, prevent, detect, treat, and cure disease based on the discovery of human and microbial genes.
| Argeris N Karabelas "Jerry"Chairman | H Thomas WatkinsPresident/CEO |
| David P SouthwellExec VP/CFO | Barry A LabingerExec VP/Chief Commercial Ofcr |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page